What's new

Human medicines European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva, efavirenz,emtricitabine,tenofovir disoproxil, Date of authorisation: 17/07/2017, Revision: 12, Status: Authorised

Human medicines European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva, efavirenz,emtricitabine,tenofovir disoproxil, Date of authorisation: 17/07/2017, Revision: 12, Status: Authorised

Mar 19, 2025 - 09:19
 0
Human medicines European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva, efavirenz,emtricitabine,tenofovir disoproxil, Date of authorisation: 17/07/2017, Revision: 12, Status: Authorised
Human medicines European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva, efavirenz,emtricitabine,tenofovir disoproxil, Date of authorisation: 17/07/2017, Revision: 12, Status: Authorised
Read More

Tags:

Previous Article

Wabtec to acquire Dellner Couplers in USD 960 million deal

Next Article

On‐Demand Removal of Rapid Hemostatic Sponge for Non‐Compressible Hemorrhage Thr...

Related Posts

2024-2026 Work Plan of the Good Clinical Practice Inspe...

Mar 17, 2025  0

Type-IA variations: questions and answers

Type-IA variations: questions and answers

Feb 19, 2025  0

Human medicines European public assessment report (EPAR): Tarceva, erlotinib, Date of authorisation: 19/09/2005, Revision: 34, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025  0